Genome-wide gene expression signature of depression identifies potential novel mechanisms and treatment targets. 57 brain and 21 peripheral DEGs are replicated at genome-wide level in depression. Functional overlap between brain and periphery links depression and CVD. Dermal fibroblasts are a promising experimental model for depression biomarker research. Gene PXMP2 is a proposed novel candidate for pathophysiology of depression.